Allergan Inc (AGN)

AGN on New York Consolidated

165.56USD
22 Aug 2014
Price Change (% chg)

$1.18 (+0.72%)
Prev Close
$164.38
Open
$163.50
Day's High
$166.58
Day's Low
$162.14
Volume
1,558,929
Avg. Vol
2,589,398
52-wk High
$174.49
52-wk Low
$86.95

AGN

Chart for AGN

About

Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. The Company’s segments include specialty pharmaceuticals, which produces a range of pharmaceutical products, including ophthalmic products for dry eye,... (more)

Overall

Beta: 0.75
Market Cap (Mil.): $48,729.23
Shares Outstanding (Mil.): 297.18
Dividend: 0.05
Yield (%): 0.12

Financials

  AGN Industry Sector
P/E (TTM): 37.56 32.67 33.58
EPS (TTM): 4.37 -- --
ROI: 14.59 18.00 17.30
ROE: 21.11 18.64 18.05
Search Stocks

Valeant, Ackman get October 6 trial over Allergan special meeting

WILMINGTON Del. - Valeant Pharmaceuticals International Inc and activist investor William Ackman got their request for an expedited trial on Wednesday over the timing of a special meeting of Allergan Inc shareholders, a key to their $49 billion hostile takeover fight.

12:15pm EDT

UPDATE 1-Valeant, Ackman get Oct. 6 trial over Allergan special meeting

WILMINGTON, Del., Aug 27 - Valeant Pharmaceuticals International Inc and activist investor William Ackman got their request for an expedited trial on Wednesday over the timing of a special meeting of Allergan Inc shareholders, a key to their $49 billion hostile takeover fight.

12:08pm EDT

Delaware judge fast-tracks Valeant, Pershing lawsuit over Allergan special meeting

Aug 27 - A Delaware judge granted a request by Valeant Pharmaceuticals International Inc and Pershing Square Capital Management for expedited proceedings in a special meeting dispute with Allergan Inc.

11:45am EDT

Facing shareholder demands, Allergan calls special meeting for December 18

- Allergan Inc said on Tuesday that it has scheduled a special shareholders meeting for Dec. 18, when activist investor Bill Ackman, who supports a hostile bid for the company by Valeant Pharmaceuticals Inc, will attempt to oust most of its board.

26 Aug 2014

UPDATE 1-Facing shareholder demands, Allergan calls special meeting for Dec. 18

Aug 26 - Allergan Inc said on Tuesday that it has scheduled a special shareholders meeting for Dec. 18, when activist investor Bill Ackman, who supports a hostile bid for the company by Valeant Pharmaceuticals Inc, will attempt to oust most of its board.

26 Aug 2014

Allergan, facing shareholder demands, calls special meeting for December 18

- Allergan Inc said on Tuesday that it has scheduled a special shareholders meeting for Dec. 18, when activist investor Bill Ackman, who supports a hostile bid for the company by Valeant Pharmaceuticals Inc, will attempt to oust most of its board.

26 Aug 2014

Allergan, facing shareholder demands, calls special meeting for Dec. 18

Aug 26 - Allergan Inc said on Tuesday that it has scheduled a special shareholders meeting for Dec. 18, when activist investor Bill Ackman, who supports a hostile bid for the company by Valeant Pharmaceuticals Inc, will attempt to oust most of its board.

26 Aug 2014

Ackman, other shareholders ask Allergan to call special meeting

BOSTON/NEW YORK - Investors owning 31 percent of shares of Allergan Inc have asked the company to call a special shareholder meeting, activist shareholder William Ackman said on Friday, giving the hedge fund manager a victory in his fight to acquire the Botox maker.

22 Aug 2014

Ackman, other shareholders ask Allergan to call special meeting

BOSTON/NEW YORK - Investors owning 31 percent of shares of Allergan Inc have asked the company to call a special shareholder meeting, activist shareholder William Ackman said on Friday, giving the hedge fund manager a victory in his fight to acquire the Botox maker.

22 Aug 2014

UPDATE 2-Ackman, other shareholders ask Allergan to call special meeting

BOSTON/NEW YORK, Aug 22 - Investors owning 31 percent of shares of Allergan Inc have asked the company to call a special shareholder meeting, activist shareholder William Ackman said on Friday, giving the hedge fund manager a victory in his fight to acquire the Botox maker.

22 Aug 2014

Competitors

  Price Change
Astellas Pharma Inc (4503.T) ¥1,522 +3.00
Santen Pharmaceutical Co Ltd (4536.T) ¥6,130 -50.00
Lupin Limited (LUPN.NS) Rs1,250.55 +12.85
Nestle SA (NESN.VX) CHF70.90 +0.10
Johnson & Johnson (JNJ.N) $103.08 -0.36
Pfizer Inc. (PFE.N) $29.53 +0.32
Novartis AG (NOVN.VX) CHF82.30 +0.10
High Tech Pharm Co.,Ltd. (106190.KQ) ₩14,750.00 -100.00
Merck & Co., Inc. (MRK.N) $60.40 +0.20
Roche Holding Ltd. (ROG.VX) CHF268.20 -1.20

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Wright Reports
$75.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks